<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-5256</journal-id>
<journal-title><![CDATA[Revista Med]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Med]]></abbrev-journal-title>
<issn>0121-5256</issn>
<publisher>
<publisher-name><![CDATA[Universidad Militar Nueva Granada. Facultad de Medicina]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-52562020000200025</article-id>
<article-id pub-id-type="doi">10.18359/rmed.5101</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Usos de la cánula nasal de alto flujo para pacientes con COVID-19. ¿Cómo funciona, cuáles son sus indicaciones? ¿Es segura en los pacientes con insuficiencia respiratoria aguda hipoxémica?]]></article-title>
<article-title xml:lang="en"><![CDATA[Uses of the high-flow nasal cannula for COVID-19 patients. How does it work an what are its indications? Is it safe or patients with acute hypoxic respiratory failure?]]></article-title>
<article-title xml:lang="pt"><![CDATA[Usos da cânula nasal de alto fluxo para pacientes com COVID-19. Como funciona e quais suas indicações? É segura nos pacientes com insuficiência respiratória aguda hipoxêmica?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hincapié Díaz]]></surname>
<given-names><![CDATA[Gustavo Adolfo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Echeverría González]]></surname>
<given-names><![CDATA[Claudia Liliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Enciso Bahamón]]></surname>
<given-names><![CDATA[Luisa Fernanda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Militar Nueva Granada  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Militar Nueva Granada  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Militar Nueva Granada  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>28</volume>
<numero>2</numero>
<fpage>25</fpage>
<lpage>34</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-52562020000200025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-52562020000200025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-52562020000200025&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La pandemia por coronavirus tipo 2 o SARS-CoV-2 tiene en jaque al sistema sanitario mundial dada su alta tasa de contagio; ha hecho colapsar todos los sistemas de salud y ha puesto en evidencia la escasez de recursos como los elementos de protección y la cantidad insuficiente de ventiladores en relación con el número de pacientes con falla respiratoria aguda hipoxémica. Por estas razones, se ha tenido que recurrir a diferentes opciones, una de ellas la cánula de alto flujo, que permite administrar oxígeno a alto flujo a los pacientes con hipoxemia severa. Durante la pandemia por COVID-19, se ha generado la inquietud acerca de que este dispositivo, como todos los dispositivos que permiten la administración de oxígeno, produce gran dispersión de aerosoles y la posibilidad de contagio del personal de la salud, lo cual ha llevado a desestimar su uso y utilizar de manera casi exclusiva la cánula nasal convencional y la ventilación mecánica en sujetos infectados. De manera que en este trabajo, se realizó una revisión de la literatura que recoge los mecanismos de acción, su seguridad para el personal de salud y las indicaciones del uso de la cánula nasal de alto flujo en los pacientes infectados por COVID-19 así como sus ventajas; entre ellas, ser dispositivo ahorrador de ventiladores mecánicos, lo que puede ser muy útil en el manejo de los pacientes en caso de un pico epidémico en Colombia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: The coronavirus type 2 or SARS-CoV-2 pandemic has held a threat over the world health system due to its high transmission rate. It has made all health systems collapse and has made evident the lack of resources such as personal protection elements and the insufficient number of ventilators for the number of patients with acute hypoxic respiratory failure. Due to his reasons, many options have been used as an alternative, being the high-flow nasal cannula one of them since it allows administering high-flow oxygen to patients with severe hypoxemia. During the COVID-19 epidemic, a concern has raised regarding this device as well as all devices used to supply oxygen to patients since they produce great dispersion of aerosols and the possibility of transmission to clinicians and staff. This has led to reject its use and give almost exclusive preference to the use of conventional cannula and mechanical ventilators with infected patients. Therefore, this study reviews the literature dealing with the high-flow nasal cannula action mechanisms, its safety for health workers and its indications for patients infected with COVID-19, as well as its advantages; amongst them, being a device that prevents the use of mechanical ventilators, which can be useful when managing patients in case of an epidemiological peak in Colombia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: A pandemia pelo coronavírus tipo 2, SARS-CoV-2, põe em xeque o sistema sanitário mundial tendo em vista sua alta taxa de contágio. Além disso, tem feito colapsar todos os sistemas de saúde e evidenciado a escassez de recursos como os elementos de proteção e a quantidade insuficiente de ventiladores para o número de pacientes com insuficiência respiratória aguda hipoxêmica. Por essas razões, recorre-se a diferentes opções, uma delas a cânula de alto fluxo, que permite administrar oxigénio a alto fluxo aos pacientes com hipoxemia severa. Durante a pandemia pela COVID-19, muitas dúvidas são geradas sobre esse dispositivo, como todos os dispositivos que permitem o manejo do oxigênio, produz grande dispersão de aerossóis e a possibilidade de contágio da equipe de saúde, o que tem levado a desestimar seu uso e a utilizar de maneira quase exclusiva a cânula nasal convencional e a ventilação mecânica em sujeitos infectados. Assim, neste trabalho, foi realizada uma revisão da literatura que coleta os mecanismos de ação, sua segurança para a equipe de saúde e as indicações do uso da cânula nasal de alto fluxo nos pacientes com COVID-19, bem como suas vantagens; entre elas, ser dispositivo que dispensa ventiladores mecânicos, o que pode ser muito útil no manejo dos pacientes caso haja um pico epidêmico na Colômbia.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[pandemia]]></kwd>
<kwd lng="es"><![CDATA[insuficiencia respiratoria hipoxémica]]></kwd>
<kwd lng="es"><![CDATA[cánula nasal de alto flujo]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[pandemic]]></kwd>
<kwd lng="en"><![CDATA[hypoxic respiratory failure]]></kwd>
<kwd lng="en"><![CDATA[high-flow nasal cannula]]></kwd>
<kwd lng="pt"><![CDATA[COVID-19]]></kwd>
<kwd lng="pt"><![CDATA[pandemia]]></kwd>
<kwd lng="pt"><![CDATA[insuficiência respiratória hipoxêmica]]></kwd>
<kwd lng="pt"><![CDATA[cânula nasal de alto fluxo]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wei-jie]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng-yi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wen-hua]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chun-quan]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Jian-xing]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characteristics of coronavirus disease 2019 in China]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
<volume>382</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>1708-20</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Alocución de apertura del director general de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xiaobo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yuan]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Jiqian]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Huaqing]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jia&#8217;an]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical course and outcomes of critically ill patients with sars-cov-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2020</year>
<volume>8</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>475-81</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hui]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Chow]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Lo]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tsang]]></surname>
<given-names><![CDATA[OTY]]></given-names>
</name>
<name>
<surname><![CDATA[Ko]]></surname>
<given-names><![CDATA[FW]]></given-names>
</name>
<name>
<surname><![CDATA[Ng]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2019</year>
<volume>53</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1802339</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ip]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Hui]]></surname>
<given-names><![CDATA[DSC]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[ALN]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[MTV]]></given-names>
</name>
<name>
<surname><![CDATA[Joynt]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Airflow and droplet spreading around oxygen masks: a simulation model for infection control research]]></article-title>
<source><![CDATA[Am J Infect Control]]></source>
<year>2007</year>
<volume>35</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>684-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scheaua]]></surname>
<given-names><![CDATA[FD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Theoretical approaches regarding the Venturi effect]]></article-title>
<source><![CDATA[Hidraulica]]></source>
<year>2016</year>
<numero>3</numero>
<issue>3</issue>
<page-range>69-72</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dysart]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Wolfson]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Shaffer]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Research in high flow therapy: mechanisms of action]]></article-title>
<source><![CDATA[Respir Med]]></source>
<year>2009</year>
<volume>103</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1400-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lodeserto]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lettich]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Rezaie]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flow nasal cannula: mechanisms of action and adult and pediatric indications]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2018</year>
<volume>10</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Whittle]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pavlov]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sacchetti]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Atwood]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Respiratory support for adult patients with COVID-19]]></article-title>
<source><![CDATA[JACEP Open]]></source>
<year>2020</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>95-101</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alhazzani]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Møller]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Arabi]]></surname>
<given-names><![CDATA[YM]]></given-names>
</name>
<name>
<surname><![CDATA[Loeb]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gong]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Fan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease (COVID-19)]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2020</year>
<numero>46</numero>
<issue>46</issue>
<page-range>854-87</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>National Health Service (NHS)</collab>
<source><![CDATA[Guidance for the role and use of non-invasive respiratory support in adult patients with COVID-19 (confirmed or suspected). Version 3]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>World Health Organization</collab>
<article-title xml:lang=""><![CDATA[Operational considerations for case management of COVID-19 in health facility and community. Interim guidance World Health Organization]]></article-title>
<source><![CDATA[Pediatr Med Rodz]]></source>
<year>2020</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>27-32</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Fink]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Ehrmann]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2020</year>
<volume>55</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>2000892</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cinesi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Peñuelas]]></surname>
<given-names><![CDATA[Ó]]></given-names>
</name>
<name>
<surname><![CDATA[Luján]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Egea]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Masa]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por sars-cov-2]]></article-title>
<source><![CDATA[Arch. bronconeumol]]></source>
<year>2020</year>
<volume>56</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>11-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parke]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[McGuinness]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Eccleston]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A preliminary randomized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients]]></article-title>
<source><![CDATA[Respir Care]]></source>
<year>2011</year>
<volume>56</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>265-70</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sztrymf]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Messika]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mayot]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lenglet]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Dreyfuss]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ricard]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study]]></article-title>
<source><![CDATA[J Crit Care]]></source>
<year>2012</year>
<volume>27</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>324.e9-324.e13</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frat]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Thille]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Mercat]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Girault]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ragot]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Perbet]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2015</year>
<numero>372</numero>
<issue>372</issue>
<page-range>2185-96</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rochwerg]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Granton]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[DX]]></given-names>
</name>
<name>
<surname><![CDATA[Helviz]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Einav]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Frat]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2019</year>
<numero>45</numero>
<issue>45</issue>
<page-range>563-72</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ni]]></surname>
<given-names><![CDATA[YN]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[ZA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Am J Emerg Med]]></source>
<year>2018</year>
<volume>36</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>226-33</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Caralt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Messika]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Samper]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sztrymf]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2019</year>
<volume>199</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1368-76</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zucman]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mullaert]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Roux]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Roca]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ricard]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2020</year>
<numero>46</numero>
<issue>46</issue>
<page-range>1924-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
